1 week Ago By ABMN Staff
Needham & Company LLC reissued their buy rating on shares of Personalis ( NASDAQ:PSNL – Free Report ) in a report published on Thursday, Benzinga reports. Needham & Company LLC currently has a $7.00 price objective on the stock.
PSNL has been the subject of a number of other reports. HC Wainwright reissued a “buy” rating and issued a $8.00 target price on shares of Personalis in a research note on Friday, February 28th.
Craig Hallum assumed coverage on Personalis in a research report on Monday, March 17th. They issued a “buy” rating and a $8.00 price objective for the company.
Finally, Lake Street Capital raised their target price on shares of Personalis from $7.00 to $9.00 and gave the stock a “buy” rating in a report on Wednesday, January 8th.
Five investment analysts have rated the stock with a buy rating, Based on data from MarketBeat, the stock has a consensus rating of “Buy” and a consensus price target of $7.80. Read Our Latest Research Report on PSNL Personalis Trading Up 8.
3 % Personalis ( NASDAQ:PSNL – Get Free Report ) last released its quarterly earnings data on Thursday, February 27th. The company reported ($0.23) EPS for the quarter, beating analysts’ consensus estimates of ($0.
32) by $0.09. The business had revenue of $16.
80 million during the quarter, compared to the consensus estimate of $15.48 million. Personalis had a negative return on equity of 66.
07% and a negative net margin of 104.52%. As a group, equities research analysts anticipate that Personalis will post -1.
4 earnings per share for the current fiscal year. Institutional Inflows and Outflows Institutional investors and hedge funds have recently modified their holdings of the company. Lightspeed Management Company L.
L.C. acquired a new stake in Personalis in the 4th quarter valued at approximately $47,169,000.
abrdn plc bought a new position in shares of Personalis during the 4th quarter worth approximately $1,722,000. Dimensional Fund Advisors LP raised its holdings in shares of Personalis by 144.2% in the fourth quarter.
Dimensional Fund Advisors LP now owns 410,083 shares of the company’s stock valued at $2,372,000 after purchasing an additional 242,141 shares during the last quarter. Jane Street Group LLC lifted its position in shares of Personalis by 144.3% in the fourth quarter.
Jane Street Group LLC now owns 401,314 shares of the company’s stock worth $2,320,000 after purchasing an additional 237,033 shares in the last quarter. Finally, 683 Capital Management LLC acquired a new position in Personalis during the fourth quarter worth $775,000. 61.
91% of the stock is owned by institutional investors and hedge funds. Personalis Company Profile ( Get Free Report ) Personalis, Inc develops and markets advanced cancer genomic tests and analytics primarily in the United States, Europe, and the Asia-Pacific. Its tests and analytics are used by pharmaceutical companies for translational research, biomarker discovery, and development of personalized cancer therapies, as well as advanced tests are used by physicians to detect cancer recurrence, monitor cancer evolution, and uncover insights for therapy selection.
See Also Receive News & Ratings for Personalis Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Personalis and related companies with MarketBeat.com's FREE daily email newsletter ..
